Last checked at 17 Aug 2011 10:40
Plant Health Care plc
Wednesday, 17 August 2011
PLANT HEALTH CARE plc (THE "COMPANY")
1. Additional Listing and Directors' Shareholdings
On 16 August 2011, the Company approved the allotment of 85,238 ordinary shares of 1p ("Ordinary Shares") to the following non-executive directors, in accordance with the Company's existing contractual arrangements, which comprise part of the non-executive directors' remuneration packages and are payable in lieu of a part of their fees. The shares were allotted at 52.5p per share, calculated at the closing middle market price derived from the Daily Official List on 15 August 2011.
Non-executive director | Value of remuneration used to purchase shares | Number of Ordinary Shares allotted |
Dominik Koechlin | £13,250.00 | 25,238 |
Sam Wauchope | £10,500.00 | 20,000 |
David Buckeridge | £10,500.00 | 20,000 |
Jeremy Scudamore | £10,500.00 | 20,000 |
TOTAL: | 85,238 |
Application has been made for 85,238 Ordinary Shares (the 'New Shares') to be admitted to trading on AIM and admission is expected to occur on 23 August 2011. The New Shares will rank pari passu with the Company's existing Ordinary Shares.
2. GRANT OF AWARDS UNDER 2007 LONG TERM INCENTIVE PLAN ("LTIP")
On 16 August 2011, the Company agreed to grant 60,000 Ordinary Shares to John Brady, CEO, under the Company's 2007 Long Term Incentive Plan ("LTIPs").
The shares will vest, subject to the satisfaction of certain objective performance conditions, on the announcement of the Company's final results for the year ended 2013.
3. VESTING OF SHARES UNDER 2007 LONG TERM INCENTIVE PLAN
On 16 August 2011, the Company approved the allotment of 4,000 Ordinary Shares to John Brady, CEO, following the vesting of shares awarded under the Company's 2007 Long Term Incentive Plan. The consideration paid for the shares was 1p per share.
4. AMENDMENT TO TERMS OF 2011 EQUITY INCENTIVE PLAN
On 16 August 2011, the Company approved the extension of the exercise date of 175,000 options over Ordinary Shares ("Options") granted to John Brady, CEO, from 20 August 2011 to 31 March 2012. The Options were granted under the Company's 2001 Equity Incentive Plan and all other terms remain the same.
5. DIRECTORS' HOLDINGS
Following the above-mentioned allotments of Ordinary Shares and grant of LTIPs, the beneficial interests of the directors concerned in the enlarged Ordinary Share capital of the Company are as shown below:
Name | Ordinary Share holding | Percentage of enlarged Ordinary Share capital | Share Options | LTIPs |
Dominik Koechlin | 203,829 | 0.38% | N/A | N/A |
John Brady | 68,395 | 0.13% | 1,150,000 | 303,000 |
Sam Wauchope | 126,229 | 0.24% | N/A | N/A |
David Buckeridge | 125,355 | 0.24% | N/A | N/A |
Jeremy Scudamore | 122,854 | 0.23% | N/A | N/A |
Following admission of the New Shares, the total issued share capital of the Company will be 53,121,036 Ordinary Shares, all of which have voting rights.
The above figure (53,121,036) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.
-: Ends :-
Enquiries:
Andrew C. Wood FCIS
Company Secretary
020 8866 5702
Evolution Securities Limited Tavistock Communications
Tim Worlledge/Tim Redfern Jeremy Carey/Matt Ridsdale
Tel: 020 7071 4300 Tel: 020 7920 3150